+ Main Category
+ Tell a Friend
Fill out the information below to email a friend a brief note about 'Pomology: Fruit Cultivation and Production'
+ Top 10
+ Directory Statistics
Links: 1182
Categories: 54
Registered Users: 178
Mailing List Subscribers: 24
+ Pagerank Statistics
+ Join Mailing List
Joining mailing list will entitle you to receive occasional emails informing you of news and updates to the site and any special offers that may be of interest to you.
Research > Chapter 10013
Bookmarks
Interleukin-1 critical effector molecule cytokine dysregulation graft host disease minor histocompatibility antigens.
Interleukin-1 key regulator matrix metalloproteinase-9 expression human neurons culture mouse brain trauma vivo.
Interleukin-1 motility factor human breast carcinoma cells vitro - Additive influence interleukin-6.
Interleukin-1 morphogenic cytotoxic cultured rat ovarian cells - Obligatory function heterologous, contact-independent cell-cell interaction.
Interleukin-1 cytoprotective, antisecretory, stimulates PGE2 synthesis stomach, retards gastric emptying.
Interleukin-1 involved mouse resistance Mycobacterium avium.
Interleukin-1 involved responses sleep deprivation rabbit.
Interleukin-1 linked respiratory epithelial cytopathology pertussis.
Interleukin-1 essential expression inducible NOS hepatocytes stimulated lipopolysaccharide vivo.
Interleukin-1 initiator Fallopian tube destruction Chlamydia trachomatis infection.
Interleukin-1 levels supernatant conditioned media Embryos grown autologous endometrial coculture - Correlation outcome vitro fertilization.
Interleukin-1 mediates endothelin-1-induced fever prostaglandin production preoptic region rats.
Interleukin-1 mediates guinea swine gallbladder inflammation vivo.
Interleukin-1 mediates induction tolerance global ischemia gerbil hippocampal CA1 neurons.
Interleukin-1 mediates behavioral hyperalgesia produced lithium chloride endotoxin.
Interleukin-1 modulates periprosthetic tissue structure intramedullary model particle-induced inflammation.
Interleukin-1 modulates phosphorylation proteins human osteoblastic cells.
Interleukin-1 modulates protein tyrosine phosphatase activity permeability brain endothelial cells.
Interleukin-1 modulation human placental trophoblast proliferation.
Interleukin-1 modulatory influence effect chemotherapeutic drugs localized irradiation lip, duodenum, tumor.
Interleukin-1 tumor necrosis factor-alpha antagonists inhibit graft-versus-host disease stimulated major histocompatibility barriers mice.
Interleukin-1 tumor necrosis factor-alpha augmented cytotoxic influence mycobacteria human fibroblasts - Application assessment pathogenesis medical isolates Mycobacterium tuberculosis M. avium complex.
Interleukin-1 plays major function progress Th2-mediated immunity.
Interleukin-1 plays major function vascular inflammation atherosclerosis male apolipoprotein E-knockout mice.
Interleukin-1 polymorphisms increased risk gastric cancer.
Interleukin-1 potentiates basal AVP-stimulated ACTH secretion vitro - The function CRH pre-incubation.
Interleukin-1 potentiates granulopoiesis thrombopoiesis producing hematopoietic factors vivo.
Interleukin-1 pretreatment prevents interleukin-1-induced lung leak rats.
Interleukin-1 pretreatment protects endotoxin-induced hypotension rabbits - Association decreased tumor necrosis factor levels.
Interleukin-1 production cure non-ionic surfactants murine keratinocytes cell line.
Interleukin-1 production activated macrophages surrounding loosened orthopaedic implants. potential function osteolysis.
Interleukin-1 production monocytes patients allergic asthma stimulation vitro lipopolysaccharide Dermatophagoides pteronyssinus mite allergen.
Interleukin-1 production mouse macrophages regulated feedback fashion nitric oxide.
Interleukin-1 production T-cell-depleted unmodified marrow grafts.
Interleukin-1 production patients subacute chronic Opisthorchis felineus infection.
Interleukin-1 production tumour cells human melanoma surgical specimens.
Interleukin-1 production alveolar macrophages sarcoidosis.
Interleukin-1 promotes expression phosphorylation neurofilament tau proteins vivo.
Interleukin-1 promotes hyperglycemia insulitis mice tolerant streptozotocin-induced diabetes.
Interleukin-1 promotes proliferation vascular smooth muscle cells coordination PDGF monocyte derived growth factor.
Interleukin-1 promotion MAPK-p38 overexpression experimental animals Alzheimer's disease - Potential significance tau protein phosphorylation.
Interleukin-1 receptor accessory protein interacts type II interleukin-1 receptor.
Interleukin-1 receptor accessory protein transcripts brain spleen - Kinetics peripheral administration bacterial lipopolysaccharide mice.
Interleukin-1 receptor antagonist (IL-1RA) prevents apoptosis vivo expansion human limbal epithelial cells cultivated human amniotic membrane.
Interleukin-1 receptor antagonist (IL-1ra) unable reverse cachexia rats bearing ascites hepatoma (Yoshida AH-130).
Interleukin-1 receptor antagonist (IL-1ra) production human amnion, chorion decidua.
Interleukin-1 receptor antagonist (anakinra) cure patients systemic-onset juvenile idiopathic arthritis adult onset Still disease - experience France.
Interleukin-1 receptor antagonist VNTR-polymorphism inflammatory bowel disease.
Interleukin-1 receptor antagonist allele 2 familial alopecia areata.
Interleukin-1 receptor antagonist allele - Is genetic link Henoch-Schonlein nephritis IgA nephropathy?
Interleukin-1 receptor antagonist alters answer vessel wall injury porcine coronary artery model.
Interleukin-1 receptor antagonist anakinra proves long-lasting efficacy cure refractory adult onset still's disease.
Interleukin-1 receptor antagonist interleukin-1 beta polymorphisms women recurrent miscarriage.
Interleukin-1 receptor antagonist interleukin-4 gingival crevicular fluid patients inflammatory periodontal disease.
Interleukin-1 receptor antagonist biomarker bronchiolitis obliterans syndrome lung transplant recipients.
Interleukin-1 receptor antagonist modulator gender differences febrile answer lipopolysaccharide rats.
Interleukin-1 receptor antagonist cure HIV infection.
Interleukin-1 receptor antagonist attenuates leukocyte-endothelial interactions liver hemorrhagic shock rat.
Interleukin-1 receptor antagonist attenuates regional neuronal cell death cognitive dysfunction experimental brain injury.
Interleukin-1 receptor antagonist attenuates heat stroke-induced neuronal damage reducing cerebral ischemia rats.
Interleukin-1 receptor antagonist attenuates tumor necrosis factor-induced alterations wound breaking strength.
Interleukin-1 receptor antagonist blocks interleukin-1-induced expression cyclooxygenase-2 endometrium.
Interleukin-1 receptor antagonist decreases severity experimental acute pancreatitis.
Interleukin-1 receptor antagonist decreases number necrotic neurons rats middle cerebral artery occlusion.
Interleukin-1 receptor antagonist displays intrinsic agonist activity rat gastric fundus motility vitro.
Interleukin-1 receptor antagonist reverse lipopolysaccharide-induced inhibition water intake rat.
Interleukin-1 receptor antagonist exerts agonist activity hippocampus independent interleukin-1 type I receptor.
Interleukin-1 receptor antagonist expression epithelial cells human endometrium.
Interleukin-1 receptor antagonist expression sarcoidosis.
Interleukin-1 receptor antagonist eye drops promoting high-risk corneal allografts survival rats.
Interleukin-1 receptor antagonist gene (IL-1RN) polymorphism predictive factor medical pregnancy IVF.
Interleukin-1 receptor antagonist gene polymorphism affects progression chronic renal failure.
Interleukin-1 receptor antagonist gene polymorphism mortality patients severe sepsis.
Interleukin-1 receptor antagonist gene polymorphism multifetal pregnancy outcome.
Interleukin-1 receptor antagonist gene polymorphism disease severity factor systemic lupus erythematosus.
Interleukin-1 receptor antagonist gene polymorphism human colorectal cancer.
Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, vaginal Ureaplasma urealyticum colonization pregnant women.
Interleukin-1 receptor antagonist gene polymorphisms patients coronary heart disease.
Interleukin-1 receptor antagonist halts progression established crescentic glomerulonephritis rat.
Interleukin-1 receptor antagonist haplotype prostate cancer risk.
Interleukin-1 receptor antagonist improves survival preserves organ adenosine-5-triphosphate hemorrhagic shock.
Interleukin-1 receptor antagonist cord blood - Influences labor fetal distress.
Interleukin-1 receptor antagonist head neck squamous cell carcinoma.
Interleukin-1 receptor antagonist inflammatory exudate cells rabbits - Production, purification measurement primary formation.
Interleukin-1 receptor antagonist patients active systemic lupus erythematosus.
Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease
Interleukin-1 receptor antagonist fetomaternal compartment.
Interleukin-1 receptor antagonist increases survival rat heatstroke reducing hypothalamic serotonin release.
Interleukin-1 receptor antagonist induction mechanism liver receptor homolog-1 negatively regulate hepatic acute phase answer.
Interleukin-1 receptor antagonist inhibits endotoxin fever systemic interleukin-6 induction rat.
Interleukin-1 receptor antagonist inhibits growth modulation human tumor cell lines interleukin-1 vitro.
Interleukin-1 receptor antagonist inhibits neuronal damage attributable fluid percussion injury rat.
Interleukin-1 receptor antagonist inhibits proteoglycan breakdown antigen stimulated polycation stimulated arthritis rabbit.
Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth vivo.
Interleukin-1 receptor antagonist inhibits expression vascular endothelial growth factor colorectal carcinoma.
Interleukin-1 receptor antagonist inhibits hypercalcemia mediated interleukin-1.
Interleukin-1 receptor antagonist inhibits transient increase plasma corticosterone initial phase trimethyltin-induced hippocampal necrosis.
Interleukin-1 receptor antagonist intervenes signaling diverse types synoviocytes rats adjuvant arthritis.
Interleukin-1 receptor antagonist lipid metabolism inflammation rheumatoid arthritis.
Interleukin-1 receptor antagonist detectable human carotid artery plaques similar triglyceride levels Chlamydia pneumoniae IgA antibodies.
Interleukin-1 receptor antagonist mRNA expression progression gastric carcinoma.
Interleukin-1 receptor antagonist modifies vital organs stimulated acute necrotizing pancreatitis rat experimental model.
Interleukin-1 receptor antagonist penetrates human brain artificially therapeutic concentrations.
Interleukin-1 receptor antagonist plasma concentration specifically increased alpha-2A-interferon cure.
Interleukin-1 receptor antagonist prevents embryonic implantation direct influence endometrial epithelium.
Interleukin-1 receptor antagonist prevents expression metalloproteinase-generated neoepitope VDIPEN antigen-induced arthritis.
Interleukin-1 receptor antagonist prevents dose streptozotocin stimulated diabetes mice.
Interleukin-1 receptor antagonist prevents sepsis-induced inhibition protein synthesis.
Interleukin-1 receptor antagonist production cultured synovial cells patients rheumatoid arthritis osteoarthritis.
Interleukin-1 receptor antagonist protein mRNA rat adrenal gland.
Interleukin-1 receptor antagonist protein inhibits synthesis IgE proinflammatory cytokines allergen-stimulated mononuclear cells.
Interleukin-1 receptor antagonist suppresses Langerhans cell activity promotes ocular immune privilege.
Interleukin-1 receptor antagonist suppresses contact hypersensitivity.
Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) rats influencing activation proliferation encephalitogenic cells.
Interleukin-1 receptor antagonist suppresses neurotrophin answer injured rat brain.
Interleukin-1 receptor antagonist synthesis peripheral blood mononuclear cells hemodialysis patients.
Interleukin-1 receptor antagonist therapy induction anterior chamber-associated immune deviation-type tolerance corneal transplantation.
Interleukin-1 receptor antagonist transiently impairs antibacterial defense survival murine pneumococcal pneumonia.
Interleukin-1 receptor antagonist, soluble tumor necrosis factor-a receptor type I II soluble E-selectin serum levels multiple sclerosis patients receiving weekly intramuscular injections interferon-beta1a.
Interleukin-1 receptor antagonist - An index dialysis-induced interleukin-1 production.
Interleukin-1 receptor antagonist - Characterisation gene expression rabbit tissues large-scale expression eucaryotic cells baculovirus expression scheme.
Interleukin-1 receptor antagonist - Influenceiveness interleukin-1 fever.
Interleukin-1 receptor antagonist - function biology.
Interleukin-1 receptor antagonists markers colorectal cancer patients.
Interleukin-1 receptor kinase-1 -2 synergetically activate NF-kappaB.
Interleukin-1 receptor blockade reduces number size murine B16 melanoma hepatic metastases.
Interleukin-1 receptor cluster - Gene organization IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), IL18R1 (IL-1Rrp) human chromosome 2q.
Interleukin-1 receptor insufficiency brains NZB (NZB/NZW)F1 autoimmune mice.
Interleukin-1 receptor insufficiency hippocampal structure (NZB times NZW)F2 mice - Genetic molecular investigations relating autoimmunity.
Interleukin-1 receptor expression ovine afferent lymph dendritic cells - Response secondary antigen challenge.
Interleukin-1 receptor immunoreactivity sympathetic vascular non-vascular neurons guinea-pig coeliac ganglion.
Interleukin-1 receptor signaling tumor necrosis factor critical protecting host severe consequences polymicrobe anaerobic infection.
Interleukin-1 receptor type 1 essential control cerebral systemic listeriosis.
Interleukin-1 receptor type I gene-lacking bile duct-ligated mice partially protected endotoxin.
Interleukin-1 receptor type I gene-lacking mice vulnerable Staphylococcus epidermidis biomaterial-associated infection wild-type mice.
Interleukin-1 receptor type I mRNA mouse brain affected peripheral administration bacterial lipopolysaccharide.
Interleukin-1 receptor type I mRNA levels brain regions male female rats.
Interleukin-1 receptor-associated kinase TRAF-6 mediate transcriptional regulation interleukin-2 interleukin-1 NFkappaB interleukin-1 unable stabilise interleukin-2 mRNA.
Interleukin-1 receptor-associated kinase gene Il1rak maps mouse X chromosome.
Interleukin-1 receptors type I type II differentially regulated human keratinocytes ultraviolet B radiation.
Interleukin-1 receptors type I type II mouse brain - Kinetics mRNA expressions peripheral administration bacterial lipopolysaccharide.
Interleukin-1 reduces systemic inflammatory answer murine model intestinal ischemia/reperfusion.
Interleukin-1 regulates FGF-2 mRNA localization FGF-2 protein human osteoblasts.
Interleukin-1 regulates interleukin-6 secretion human oral squamous cell carcinoma vitro - Possible effect p53 human papillomavirus E6/E7.
Interleukin-1 regulates proliferation differentiation oligodendrocyte progenitor cells.
Interleukin-1 regulates zinc metabolism metallothionein gene expression.
Interleukin-1 regulation collecting duct prostaglandin E-2 cyclic nucleotide accumulation.
Interleukin-1 regulation corticotropin-releasing factor (CRF), glucocorticoid receptor, c-fos c-jun messenger RNA NPLC-KC cell line.
Interleukin-1 represses COLIA1 promoter activity calvarial bones transgenic ColCAT mice vitro vivo.
Interleukin-1 science.
Interleukin-1 answer arterial antigen, lipopolysaccharide, oxidized density lipoprotein ischemic heart disease.
Interleukin-1 selectively potentiates bradykinin-stimulated arachidonic acid release human synovial fibroblasts.
Interleukin-1 signal transduction.
Interleukin-1 signal transduction interaction nervous immune systems.
Interleukin-1 signaling mouse astrocytes involves Akt. study interleukin-4 interleukin-10.
Interleukin-1 signaling essential host defense murine pulmonary tuberculosis.
Interleukin-1 signaling modulates stress-induced analgesia.
Interleukin-1 induced activation COT catalytic subunit phosphorylation Thr290 Ser62.
Interleukin-1 stimulates Jun N-terminal/stress-activated protein kinase arachidonate-dependent mechanism mesangial cells.
Interleukin-1 stimulates aldosterone secretion - Involvement renin, ACTH, prostaglandins.
Interleukin-1 stimulates aldosterone secretion - involvement renin, ACTH, prostaglandins.
Interleukin-1 stimulates beta-cell necrosis release immunological adjuvant HMGB1.
Interleukin-1 stimulates catecholamine release hypothalamus.
Interleukin-1 stimulates cytokines, prostaglandin E2 matrix metalloproteinase-1 production activation MAPK/AP-1 NF-kappaB human gingival fibroblasts.
Interleukin-1 stimulates de novo synthesis mitogen-activated protein kinase glomerular mesangial cells.
Interleukin-1 stimulates deoxyribonucleic acid synthesis immature rat Leydig cells vitro.
Interleukin-1 stimulates human uterine prostaglandin production induction cyclooxygenase-2 expression.
Interleukin-1 stimulates hypothalamic inhibitory amino acid neurotransmitter release.
Interleukin-1 stimulates macrophage migration inhibitory factor secretion ectopic endometrial cells women endometriosis.
Interleukin-1 stimulates phosphatidic acid-mediated phospholipase D activity human mesangial cells.
Interleukin-1 stimulates release insulin-like growth factor-I neonatal mouse calvaria prostaglandin synthesis-dependent mechanism.
Interleukin-1 stimulates the release corticotropin-releasing hormone primate.
Interleukin-1 stimulates expression type I type II interleukin-1 receptors rat insulinoma cell line Rinm5F; sequencing rat type II interleukin-1 receptor cDNA.
Interleukin-1 stimulates release dopamine dihydroxyphenylacetic acid hypothalamus vivo.
Interleukin-1 stimulates release interleukin-6 cultured human pituitary adenoma cells.
Interleukin-1 stimulates tumor necrosis factor-alpha (TNF-alpha) release cytotrophoblastic BeWo cells independently induction TNF-alpha mRNA.
Interleukin-1 stimulation equine articular cells.
Interleukin-1 superfamily genes expression normal impaired human spermatogenesis.
Interleukin-1 suppresses follicle-stimulating hormone-induced estradiol secretion cultured ovarian granulosa cells.
Interleukin-1 scheme sex steroid receptor gene expression human endometrial cancer.
Interleukin-1 scheme crosstalk embryo endometrium implantation.
Interleukin-1 scheme CNS stress: Seizures, fever, neurotrauma.
Interleukin-1 scheme mammalian reproduction.
Interleukin-1 type I receptor messenger ribonucleic acid expression human endometrium menstrual cycle.
Interleukin-1 type II receptor. decoy target IL-1 regulated IL-4.
Interleukin-1 upregulates anaphylatoxin receptors mononuclear cells.
Interleukin-1 upregulates decorin production arterial smooth muscle cells.
Interleukin-1(beta) induces CREB-binding protein (CBP) niRNA brain sequencing rat CBP.
Interleukin-1, -6 tumor necrosis factor-alpha release down-regulated blood septic patients.
Interleukin-1, Interleukin-6 germ cell-Sertoli cell cross-talk.
Interleukin-1, TNF-alpha naturally occurring antagonists sepsis.
Interleukin-1, anorexia, dietary fatty acids.
Interleukin-1, inflammation disease.
Interleukin-1, interleukin-1 receptor antagonist macrophage populations rheumatoid arthritis synovial membrane.
Interleukin-1, interleukin-1 receptor, interleukin-1 receptor antagonist.
Interleukin-1, interleukin-10 tumour necrosis factor-alpha gene polymorphisms hepatitis C virus infection - An investigation relationships spontaneous viral clearance answer alpha-interferon therapy.
Interleukin-1, interleukin-6 tumor necrosis factor delivery preeclamptic disorders.
Interleukin-1, interleukin-6 tumor necrosis factor-alpha activity patients viral hepatitis.
Interleukin-1, interleukin-6, tumor necrosis factor produced mouse uterus estrous cycle stimulated estrogen progesterone.
Interleukin-1, neuroinflammation, Alzheimer's disease.
Interleukin-1, nitric oxide reactive astrocytes.
Interleukin-1, tumor necrosis factor lipopolysaccharide additively induce production adrenomedullin vascular smooth muscle cells.
Interleukin-1, tumor necrosis factor special inhibitors.
Interleukin-1- beta modulation prolactin secretion rat anterior pituitary cells - involvement adenylate cyclase activity calcium mobilization.
Interleukin-1-BETA release rat gastric fundus.
Interleukin-1-BETA stimulates cell proliferation intermediate lobe rat pituitary gland.
Interleukin-1-alpha ad interleukin-1-beta levels amniotic fluid pregnancy - Correlation microbial invasion amniotic cavity.
Interleukin-1-alpha -beta modulation luteinized human granulosa cell oestrogen progesterone biosynthesis.
Interleukin-1-alpha beta growth plate cartilage regulated vitamin D metabolites vivo.
Interleukin-1-alpha de novo mammalian angiogenesis.
Interleukin-1-alpha epidermal growth factor synergistically enhance release collagenase periosteal connective tissue vitro.
Interleukin-1-alpha interleukin-1 receptor antagonist urine children acute pyelonephritis relationship renal scarring.
Interleukin-1-alpha interleukin-1-beta induce adrenocorticotropin secretion rat related hypothalamic receptor(s) - Influences interleukin-1 receptor antagonist protein.
Interleukin-1-alpha interleukin-2 cerebrospinal fluid schizophrenic subjects.
Interleukin-1-alpha interleukin-6 act additively inhibit growth MCF-7 breast cancer cells vitro.
Interleukin-1-alpha tumour necrosis factor inhibit rat gastric fundus motility vitro.
Interleukin-1-alpha biomarker epidermal answer mononuclear cell-derived cytokines inflammatory stimuli.
Interleukin-1-alpha autocrine growth factor acute lymphoblastic leukaemia cells.
Interleukin-1-alpha enhances biosynthesis complement C3 factor B human kidney proximal tubular epithelial cells vitro.
Interleukin-1-alpha gene expression localization interleukin-1-alpha protein tumor promotion.
Interleukin-1-alpha gene expression wound healing.
Interleukin-1-alpha blood direct access cortical brain cells.
Interleukin-1-alpha human sweat functionally active derived eccrine sweat gland.
Interleukin-1-alpha induces corticotropin-releasing factor secretion synthesis NPLC-KC cells messenger pathways.
Interleukin-1-alpha induces accumulation cytosolic phospholipase A-2 release prostaglandin E-2 human fibroblasts.
Interleukin-1-alpha released transfection keratinocytes.
Interleukin-1-alpha mediates enhanced expression intercellular adhesion molecule-1 pulmonary epithelial cells infested respiratory syncytial virus.
Interleukin-1-alpha produced human gingival fibroblasts induces activities similar progression periodontitis direct contact.
Interleukin-1-alpha production Rickettsia rickettsii infection cultured endothelial cells - Potential function autocrine cell stimulation.
Interleukin-1-alpha reduces severity vascular leak syndrome produced interleukin-2 interleukin-2 interferon-alpha.
Interleukin-1-alpha regulates Thy-1 expression rat vascular endothelial cells.
Interleukin-1-alpha stimulates KC synthesis rat mesangial cells - Glucocorticoids inhibit KC induction IL-1.
Interleukin-1-alpha stimulates dopamine release activating type II protein kinase A PC-12 cells.
Interleukin-1-alpha stimulates keratinocyte migration epidermal growth factor/transforming growth factor-alpha-independent pathway.
Interleukin-1-alpha suppresses gap junction-mediated intercellular communication human endothelial cells.
Interleukin-1-alpha upregulates expression surfactant protein-A rabbit lung explants.
Interleukin-1-alpha, interleukin-1-beta, co-mitogen neonatal rat Schwann cells vitro acts interleukin-1 receptors.
Interleukin-1-alpha, interleukin 6 tumor necrosis factor alpha increase synthesis expression functional alternative terminal complement pathways human umbilical vein endothelial cells vitro.
Interleukin-1-alpha, interleukin-1-beta tumor necrosis factor gene expression endotoxin-induced uveitis.
Interleukin-1-alpha, soluble interleukin-2 receptor, IgG concentrations cystic fibrosis treated prednisolone.
Interleukin-1-alpha-induced modulation topoisomerase I activity DNA damage - Implications mechanisms synergy camptothecins vitro vivo.
Interleukin-1-alpha-mediated promotion long-term alloengraftment short-term neutrophil expansion require presence donor host C cells.
Interleukin-1-beta (IL-1-beta) acute leukemia - In vitro proliferative answer IL-1-beta, IL-1-beta content leukemic cells cure outcome.
Interleukin-1-beta (IL-1-beta) tumour necrosis factor (TNF) inhibit long-term potentiation rat dentate gyrus vitro.
Interleukin-1-beta (IL-1-beta) induces transforming growth factor-beta-1 (TGF-beta-1) production rat aortic smooth muscle cells.
Interleukin-1-beta (IL-1-beta) increased follicular fluids patients premature luteinization.
Interleukin-1-beta (IL-1-beta), IL-1 receptor antagonist, TNF-alpha production blood.
Interleukin-1-beta (IL-1-beta)-induced modulation hypothalamic IL-1-beta system, tumor necrosis factor-alpha, transforming growth factor-beta-1 mRNAs obese (fa/fa) lean (Fa/Fa) Zucker rats - Implications IL-1-beta feedback systems cytokine-cytokine interactions.
Interleukin-1-beta activates PI 3-kinase renal mesangial cells.
Interleukin-1-beta activates c-jun NH-2-terminal kinase subgroup mitogen-activated protein kinases mesangial cells.
Interleukin-1-beta activation cultured glomerular epithelial cells.
Interleukin-1-beta acts hypothalamic sites inhibit gastric acid secretion rats.
Interleukin-1-beta IgG subclass concentrations gingival crevicular fluid patients adult periodontitis.
Interleukin-1-beta granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently.
Interleukin-1-beta ibuprofen effects CD4/CD8 cells endotoxic challenge.
Interleukin-1-beta interferon gamma interact fibroblast growth factor-2 control neuroblastoma cell proliferation differentiation.
Interleukin-1-beta interleukin-4 increase parathyroid hormone-related protein secretion human umbilical vein endothelial cells culture.
Interleukin-1-beta interleukin-6 elevated cerebrospinal fluid Alzheimer's de novo Parkinson's disease patients.
Interleukin-1-beta interleukin-6 stimulate intercellular adhesion molecule-1 (ICAM-1) gene expression rat thyroid cell line, FRTL-5.
Interleukin-1-beta interleukin-6 induce 2-methylaminoisobutyric acid absorption HepG2 cells.
Interleukin-1-beta interleukin-6 induce neurohypophysial hormone release vitro.
Interleukin-1-beta phenytoin reduce alpha-1procollagen mRNA expression human gingival fibroblasts.
Interleukin-1-beta transforming growth factor-beta-2 enhance cytosolic high-molecular-mass phospholipase A-2 activity stimulate prostaglandin E-2 structure rat mesangial cells.
Interleukin-1-beta tumor necrosis factor-alpha stimulate expression alpha-1-antichymotrypsin human astrocytoma cells activation nuclear factor-kappa-B.
Interleukin-1-beta tumor necrosis factor-alpha release normal diseased human infrarenal aortas.
Interleukin-1-beta tumor necrosis factor-alpha induce synergistically expression monocyte chemoattractant protein-1 fibroblastic cells derived human periodontal ligament.
Interleukin-1-beta tumor necrosis factor-alpha synergistically stimulate NO synthase rat vascular smooth muscle cells.
Interleukin-1-beta tumour necrosis factor-alpha induce mRNA expression interleukin-1 receptors mouse anterior pituitary AtT-20 cells.
Interleukin-1-beta antagonizes phenobarbital induction major cytochromes P450 adult rat hepatocytes primary culture.
Interleukin-1-beta attenuates excitatory amino acid-induced neurodegeneration vitro - Involvement nerve growth factor.
Interleukin-1-beta increase anterior hypothalamic interleukin-6 LPS-induced fever rats.
Interleukin-1-beta expression metalloproteinases vitreous humor induces membrane structure eyes preexisting retinal holes.
Interleukin-1-beta concentration gingival crevicular fluid.
Interleukin-1-beta converting enzyme murine Langerhans cells epidermal-derived dendritic cell lines.
Interleukin-1-beta converting enzyme inhibition blocks progression type II collagen-induced arthritis mice.
Interleukin-1-beta converting enzyme - Synthesis hydroxyethyl dipeptide surrogate-containing compounds potential ICE inhibitors.
Interleukin-1-beta differentially affects interleukin-6 soluble interleukin-6 receptor blood nervous scheme monkey.
Interleukin-1-beta dissociates beta-amyloid precursor protein beta-amyloid peptide secretion.
Interleukin-1-beta increase synaptic inhibition hippocampal CA3 pyramidal dentate gyrus granule cells rat vitro.
Interleukin-1-beta stimulate reactive astrogliosis, neovascularization scar structure immature rat brain.
Interleukin-1-beta enhances tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity MC3T3-E1 osteoblastic cells.
Interleukin-1-beta enhances capsaicin-induced neurogenic vasodilation rat skin.
Interleukin-1-beta enhances spinal cord blood flow intrathecal administration normal rat.
Interleukin-1-beta enhances survival interleukin-6 protects MPP+ neurotoxicity cultures fetal rat dopaminergic neurons.
Interleukin-1-beta enhances answer human articular chondrocytes extracellular ATP.
Interleukin-1-beta expression stimulated adherence enhanced Fc-receptor binding immune complex THP-1 cells.
Interleukin-1-beta gene expression experimental glomerulonephritis rat - An in-situ hybridization study.
Interleukin-1-beta gene expression human oral polymorphonuclear leukocytes.
Interleukin-1-beta excitatory effects neurons bed nucleus stria terminalis.
Interleukin-1-beta dorsal vagal complex inhibits TRH analogue-induced stimulation gastric contractility.
Interleukin-1-beta increases 5-hydroxyindoleacetic acid release hypothalamus vivo.
Interleukin-1-beta increases basic fibroblast growth factor mRNA expression adult rat brain organotypic hippocampal cultures.
Interleukin-1-beta increases prostaglandin E-2-stimulated adenosine 3,5-cyclic monophosphate production rabbit pigmented ciliary epithelium.
Interleukin-1-beta independently stimulates production prostaglandin E-2 cyclic AMP human decidual cells.
Interleukin-1-beta stimulated activation NF-kappa-B insulin producing RINm5F cells prevented protease inhibitor N-alpha-p-tosyl-l-lysine chloromethylketone.
Interleukin-1-beta stimulated corticosterone altitude hypothalamic NE depletion vagally mediated.
Interleukin-1-beta induced-desArg-9bradykinin-mediated thermal hyperalgesia rat.
Interleukin-1-beta induces cyclic AMP structure extracted human osteoblasts. signalling mechanism similar enhanced prostaglandin structure.
Interleukin-1-beta induces cyclooxygenase-2 cultured human decidual cells.
Interleukin-1-beta induces cytosolic PLA-2 parallel prostaglandin E-2 rheumatoid synovial fibroblasts.
Interleukin-1-beta induces cytosolic phospholipase A-2 prostaglandin H synthase rheumatoid synovial fibroblasts.
Interleukin-1-beta induces cytosolic phospholipase A2 gene rat C6 glioma cell line.
Interleukin-1-beta induces differential adhesiveness human endothelial cell surfaces.
Interleukin-1-beta induces differential gene expression aortic smooth muscle cells.
Interleukin-1-beta induces expression adhesion molecules human vascular smooth muscle cells enhances adhesion leukocytes smooth muscle cells.
Interleukin-1-beta induces histamine release rat hypothalamus vivo.
Interleukin-1-beta induces interleukin-1 receptor antagonist tumor necrosis factor binding protein humans.
Interleukin-1-beta induces interstitial collagenase gene expression protein secretion renal mesangial cells.
Interleukin-1-beta induces long-term increase axonally transported opiate receptors agent P.
Interleukin-1-beta induces nitric oxide production mouse pituitary tumour cell line (AtT20/D16).
Interleukin-1-beta induces nitric oxide synthase hamster pancreas beta cell line (HIT-T15).
Interleukin-1-beta induces nuclear factor kappa-B epithelial cells independently production reactive oxygen intermediates.
Interleukin-1-beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) primary murine astrocyte cultures.
Interleukin-1-beta induces expression HSP70, heme oxygenase Mn-SOD FACS-purified rat islet beta-cells, alpha-cells.
Interleukin-1-beta induces structure nitric oxide extracted juxtaglomerular cells - Effect renin secretion.
Interleukin-1-beta induces synthesis activity cytosolic phospholipase A-2 release prostaglandin E-2 human amnion-derived WISH cells.
Interleukin-1-beta induces synthesis adenylyl cyclase Swiss 3T3 fibroblasts MG-63 osteosarcoma cells.
Interleukin-1-beta induction tissue inhibitor metalloproteinase (TIMP-1) functionally antagonized prostaglandin E-2 human synovial fibroblasts.
Interleukin-1-beta inhibits Ca-2+ channel currents hippocampal neurons protein kinase C.
Interleukin-1-beta inhibits airway smooth muscle contraction epithelium-dependent mechanism.
Interleukin-1-beta inhibits gastric histamine secretion synthesis rat.
Interleukin-1-beta inhibits glutamate release hippocampus young, aged, rats.
Interleukin-1-beta inhibits progesterone accumulation rat corpora luteal cell cultures mechanism dissociated effects nitric oxide prostaglandin E accumulation.
Interleukin-1-beta inhibits rat thyroid cell role vivo vitro NO-independent mechanism induces hypothyroidism accelerated thyroiditis diabetes-prone BB rats.
Interleukin-1-beta inhibits endogenous expression early gene c-fos located nucleus LH-RH neurons interferes hypothalamic LH-RH release proestrus rat.
Interleukin-1-beta differentially expressed human dermal papilla cells answer PKC activation potent inhibitor human hair follicle growth organ culture.
Interleukin-1-beta levels human embryo culture supernatants predictive pregnancy.
Interleukin-1-beta mRNA expression ischemic rat cortex.
Interleukin-1-beta measured radioimmunoassay rat spleen thymus increased chronic inflammatory stress.
Interleukin-1-beta modulates myocardial contraction dexamethasone sensitive production nitric oxide.
Interleukin-1-beta modulation norepinephrine release rat myenteric nerves.
Interleukin-1-beta peptides stimulate cerebral pial arteriolar dilation anesthetized newborn pigs.
Interleukin-1-beta potentiates bradykinin-induced macromolecular efflux hamster oral mucosa.
Interleukin-1-beta primes interleukin-8-stimulated chemotaxis elastase release human neutrophils type I receptor.
Interleukin-1-beta production onset heat stroke rabbits.
Interleukin-1-beta reduces daily activity degree male lizards, Sceloporus occidentalis.
Interleukin-1-beta regulates inducible cyclooxygenase amnion-derived WISH cells.
Interleukin-1-beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1
Interleukin-1-beta sensitizes answer gastric vagal afferent cholecystokinin rat.
Interleukin-1-beta specifically stimulates nitric oxide production hypothalamus.
Interleukin-1-beta stimulates adrenocorticotropin corticosterone release 10-day-old rat pups.
Interleukin-1-beta stimulates both peripheral release vasopressin oxytocin rat.
Interleukin-1-beta stimulates collagenase production cultured human periodontal ligament fibroblasts.
Interleukin-1-beta stimulates corticotropin-releasing hormone (CRH) adrenocorticotropin (ACTH) release rat adrenal gland vitro.
Interleukin-1-beta stimulates phospholipase A-2 activity adult rat ventricular myocytes.
Interleukin-1-beta stimulates prostaglandin E-2 F-2alpha synthesis human ovarian granulosa cells culture.
Interleukin-1-beta stimulates release atrial brain natriuretic peptide diverse mechanisms.
Interleukin-1-beta stimulates tyrosine hydroxylase activity median eminence.
Interleukin-1-beta stimulation 45Ca-2+ release rat striatal slices.
Interleukin-1-beta suppresses apoptosis CD34 positive bone marrow cells activation type I IL-1 receptor.
Interleukin-1-beta up-regulates plasminogen activator/plasmin scheme human mesangial cells.
Interleukin-1-beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT)
Interleukin-1-beta usual distinct signaling pathways induction interleukin-6 tumor necrosis factor alpha genes human astrocytoma cell line U373.
Interleukin-1-beta, interleukin-6, impairs spatial navigation learning.
Interleukin-1-beta, interleukin-6, epidermal growth factor transforming growth factor-alpha elevated brain parkinsonian patients.
Interleukin-1-beta, tumour necrosis factor-alpha, islet-cell antibody, insulin secretion children thalassemia major long-term blood transfusion.
Interleukin-1-beta- tumour-necrosis-factor-induced inhibition rat gastric fundus motility vitro.
Interleukin-1-beta-converting enzyme CPP32 involved ultraviolet B-induced apoptosis SV40-transformed human keratinocytes.
Interleukin-1-beta-converting enzyme mediates cisplatin-induced apoptosis malignant glioma cells.
Interleukin-1-beta-induced anorexia pyrexia rat - Relationship hypothalamic neuropeptide Y.
Interleukin-1-beta-induced cytosolic phospholipase A-2 activity protein synthesis blocked dexamethasone rat mesangial cells.
Interleukin-1-beta-induced disruption retinal vascular barrier the nervous scheme mediated leukocyte recruitment histamine.
Interleukin-1-beta-induced effects plasma oxytocin arginine vasopressin - Role adrenal steroids administration.
Interleukin-1-beta-induced expression protein kinase C (PKC)-delta epsilon NIH 3T3 cells.
Interleukin-1-beta-induced inhibition hair growth vitro mediated cyclic AMP.
Interleukin-1-beta-induced nitric oxide production activates apoptosis pancreatic RINm5F cells.
Interleukin-1-beta-induced nitric oxide production extracted rat islets modulated D-glucose 3-isobutyl-1-methyl xanthine.
Interleukin-1-beta-induced stimulation insulin release mouse pancreatic islets similar diacylglycerol production protein kinase C activation.
Interleukin-1-beta-induced, nitric oxide-dependent -independent inhibition vascular smooth muscle contraction.
Interleukin-1-beta-mediated inhibition arginase RINm5F cells.
Interleukin-1-beta-mediated regulation mu-opioid receptor mRNA primary astrocyte-enriched cultures.
Interleukin-1-beta-specific partial agonists defined site-directed mutagenesis investigations.
Interleukin-1-beta-stimulated PGE2 production early preliminary trimester human decidual cells inhibited dexamethasone progesterone.
Interleukin-1-beta-stimulated invasion articular cartilage rheumatoid synovial fibroblasts inhibited antibodies special integrin receptors collagenase inhibitors.
Interleukin-1-beta-stimulated prostaglandin synthesis human decidual cells independent protein kinase C.
Interleukin-1-beta. putative mediator HPA axis hyperactivity major depression?
Interleukin-1-beta - Usual Alzheimer's disease diabetes mellitus.
Interleukin-1-lacking mice exhibit high sensitivity gut-derived sepsis attributable Pseudomonas aeruginosa.
Interleukin-1-dependent mitogenic responses stimulated protoscoleces Echinococcus multilocularis murine lymphocytes.
Interleukin-1-induced IL-8 IL-6 gene expression production human mesangial cells differently regulated cAMP.
Interleukin-1-induced NF-kappa B activation NEMO-dependent require IKK beta.
Interleukin-1-induced NF-kappa B recruitment oxytocin receptor gene inhibits RNA polymerase II-promoter interactions cultured human myometrial cells.
Interleukin-1-induced activation protein kinase co-precipitating type I interleukin-1 receptor T cells.
Interleukin-1-induced corticosterone release occurs adrenergic mechanism rat adrenal gland.
Interleukin-1-induced cyclooxygenase 2 expression suppressed cyclosporin A rat mesangial cells.
Interleukin-1-induced expression nitric oxide synthase insulin-producing cells preceded c-fos induction depends gene transcription protein synthesis.
Interleukin-1-induced glenohumeral synovitis shoulder pain rotator cuff diseases.
Interleukin-1-induced granulocytopenia pulmonary leukostasis rabbits.
Interleukin-1-induced growth factor expression postmitotic resting fibroblasts.
Interleukin-1-induced interleukin-6 synthesis mediated neutral sphingomyelinase/Src kinase pathway neurones.
Interleukin-1-induced intracellular signaling pathways converge activation mitogen-activated protein kinase mitogen-activated protein kinase-activated protein kinase 2 succeeding phosphorylation 27-kilodalton heat shock protein monocytic cells.
Interleukin-1-induced lung neutrophil accumulation oxygen metabolite-mediated lung leak rats.
Interleukin-1-induced neurotoxicity mediated glia requires caspase activation free radical release.
Interleukin-1-induced nitric oxide production modulates glutathione synthesis cultured rat hepatocytes.
Interleukin-1-induced nonspecific resistance bacterial infection mice mediated glucocorticosteroids.
Interleukin-1-induced prostaglandin E-2 biosynthesis human synovial cells involves activation cytosolic phospholipase A-2 cyclooxygenase-2.
Interleukin-1-induced protection azidothymidine (AZT) stimulated hematopoietic toxicity.
Interleukin-1-induced sickness behavior depends behavioral lateralization mice.
Interleukin-1-induced suppression type II collagen gene transcription involves DNA regulatory elements.
Interleukin-1-inducible genes endothelial cells - Cloning gene similar C-reactive protein serum amyloid P constituent.
Interleukin-1-like activity synovial fluids sera horses arthritis.
Interleukin-1-mediated H-2O-2 production hepatic sinusoidal endothelium answer B16 melanoma cell adhesion.
Interleukin-1-mediated H2O2 production hepatic sinusoidal endothelium answer B16 melanoma cell adhesion.